ENTA
Price
$6.31
Change
+$0.45 (+7.68%)
Updated
Dec 20, 04:59 PM (EDT)
46 days until earnings call
INZY
Price
$2.98
Change
+$0.17 (+6.05%)
Updated
Dec 20, 04:59 PM (EDT)
89 days until earnings call
Ad is loading...

ENTA vs INZY

Header iconENTA vs INZY Comparison
Open Charts ENTA vs INZYBanner chart's image
Enanta Pharmaceuticals
Price$6.31
Change+$0.45 (+7.68%)
Volume$28.58K
CapitalizationN/A
Inozyme Pharma
Price$2.98
Change+$0.17 (+6.05%)
Volume$13.07K
CapitalizationN/A
ENTA vs INZY Comparison Chart
Loading...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENTA vs. INZY commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTA is a Hold and INZY is a Hold.

COMPARISON
Comparison
Dec 21, 2024
Stock price -- (ENTA: $6.31 vs. INZY: $2.99)
Brand notoriety: ENTA and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTA: 217% vs. INZY: 160%
Market capitalization -- ENTA: $133.74M vs. INZY: $192.08M
ENTA [@Biotechnology] is valued at $133.74M. INZY’s [@Biotechnology] market capitalization is $192.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTA’s FA Score shows that 1 FA rating(s) are green whileINZY’s FA Score has 0 green FA rating(s).

  • ENTA’s FA Score: 1 green, 4 red.
  • INZY’s FA Score: 0 green, 5 red.
According to our system of comparison, both ENTA and INZY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTA’s TA Score shows that 4 TA indicator(s) are bullish while INZY’s TA Score has 4 bullish TA indicator(s).

  • ENTA’s TA Score: 4 bullish, 3 bearish.
  • INZY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ENTA is a better buy in the short-term than INZY.

Price Growth

ENTA (@Biotechnology) experienced а +4.64% price change this week, while INZY (@Biotechnology) price change was -1.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

ENTA is expected to report earnings on Feb 05, 2025.

INZY is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INZY($192M) has a higher market cap than ENTA($134M). INZY YTD gains are higher at: -29.812 vs. ENTA (-32.944). INZY has higher annual earnings (EBITDA): -90.3M vs. ENTA (-104.08M). ENTA has more cash in the bank: 230M vs. INZY (132M). INZY has less debt than ENTA: INZY (46.8M) vs ENTA (50.6M). ENTA has higher revenues than INZY: ENTA (72M) vs INZY (0).
ENTAINZYENTA / INZY
Capitalization134M192M70%
EBITDA-104.08M-90.3M115%
Gain YTD-32.944-29.812111%
P/E RatioN/AN/A-
Revenue72M0-
Total Cash230M132M174%
Total Debt50.6M46.8M108%
FUNDAMENTALS RATINGS
ENTA: Fundamental Ratings
ENTA
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENTAINZY
RSI
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WONDF0.19N/A
+1.58%
Wonderfi Technologies Inc.
FEAMX14.280.12
+0.85%
First Eagle Rising Dividend Fund C
AVEWX20.110.14
+0.70%
Ave Maria World Equity
GGCCX94.09N/A
N/A
Gabelli Growth C
DVLRX60.84N/A
N/A
Delaware Small Cap Value R

ENTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTA has been loosely correlated with NTLA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTA jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTA
1D Price
Change %
ENTA100%
+7.68%
NTLA - ENTA
41%
Loosely correlated
+1.08%
SANA - ENTA
39%
Loosely correlated
+3.12%
ETNB - ENTA
39%
Loosely correlated
+12.80%
KROS - ENTA
39%
Loosely correlated
+0.65%
PGEN - ENTA
39%
Loosely correlated
+5.07%
More

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
+6.41%
BEAM - INZY
57%
Loosely correlated
+8.16%
NAUT - INZY
52%
Loosely correlated
-0.56%
ABOS - INZY
50%
Loosely correlated
+2.22%
DNLI - INZY
49%
Loosely correlated
-0.14%
RXRX - INZY
48%
Loosely correlated
-0.90%
More